Alacrita Life Science Consulting Alacrita Life Science Consulting
  • Our Services
    • Product Development
      • Research & IP Evaluation
      • Preclinical Strategy & Execution
      • Clinical Development
      • Regulatory Affairs
      • CMC Consulting
      • Interim Chief Medical Officer
    • Strategy & Commercialization
      • Opportunity Mapping
      • Business Plans & Fundraising Support
      • New Product Planning
      • Launch Planning
    • Business Development
      • Due Diligence
      • Valuations
      • In-Licensing & Asset Scouting
      • Out-Licensing, Partnering & Deal-making
    • Expert Witness Services
    • By Client Type
      • Biotech
      • Virtual & Semi-Virtual Biotechs
      • Pharmaceutical Companies
      • Investors
      • Tech Transfer Offices
      • Animal Health Companies
    • By Product Modality
      • Antibodies, ADCs
      • Cell Therapies
      • Drug Discovery Platforms
      • Gene Therapies
      • Microbiome Drugs
      • Peptides & Proteins
      • Radiopharmaceuticls
      • Small Molecules
      • Other Product Modalities
    • By Disease Area
      • CNS
      • Digestive & GI
      • Endocrine & Metabolic
      • Fibrosis
      • Hematology
      • Immunology
      • Oncology
      • Respiratory
      • Other Disease Areas
  • Core Team
    • Alastair Southwell
    • Anthony Walker
    • Saadia Anastasiou
    • Michael Lombardo
    • Lucas Rodriguez
    • Mark Philip
    • Nigel Burns
    • Gary Mansfield
    • Christine McCarthy
    • Stuart Hendry
    • Simon Turner
    • Pierre Dodion
  • Consulting Network
  • Resources
    • Case Studies
    • Blog
    • News
    • Whitepapers
  • Careers
  • Contact

Whitepapers

  • news and resources
  • Whitepapers

Paz Sanz-Magallon Duque de Estrada, Consultant Intern, and Saadia Basharat, PhD, Senior Consultant

Recent Posts

Exosome & Extracellular Vesical-Based Therapeutics & Their Potential Use in Oncology

12th November 2021
Abstract It was previously believed that exosomes, membrane-bound extracellular vesicles released by cells, were a waste disposal mechanism resulting from cell damage or from by-products of cell...
Learn More
1

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

  • Strategy and Commercialization Learn more
  • Product Development Learn more
  • Business Development Learn more

© 2009-25 Alacrita Holdings Limited  |   Pharma & Biotech Consulting

  • Privacy Notice

Alacrita Consulting 
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608


One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.

Alacrita Life Science Consulting Alacrita Life Science Consulting